Half a year has passed since the FDA authorized Pfizer’s at-home COVID-19 treatment Paxlovid for emergency use, and the two-pill regimen became the nation’s No. 1 prescribed choice by the end of May.
Read the full post on Becker's Hospital Review - Healthcare News
